RxDoctor Payments Data

Michael Lewis, MD

Anatomic Pathology & Clinical Pathology · Los Angeles, CANPI 1306047139

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $219,373 of the $220,478 with a category attached, or 99.5%. Exthera Medical Corporation accounts for 99.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $136,974, more than ten times the $581 reported in 2019. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$220,478in general payments, 2019–2025

Across 30 payments — averaging $7349.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exthera Medical Corporation$219K
  • Sanofi$430
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$273
  • AbbVie$167
  • United Therapeutics Corporation$101
  • Myriad Women's Health, Inc.$97
  • plus $38 from 2 others
$849,078in research payments, 2019–2025

Across 116 payments — averaging $7319.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$849K

What the payments were for

  • Consulting fees$219,37399%
  • Travel & lodging$2400%
  • Food & beverage$8650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$220,478 in reported general payments places this provider in the 95th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Medicare billing

Part B allowed, 2024
$21,220
Medicare patients
232
Services billed
620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →